School of Medicine
Showing 12,301-12,400 of 13,043 Results
-
Carl Gustaf Winge,MD PhD
Instructor, Dermatology
BioMårten Winge, M.D. Ph.D., is a Clinical Instructor of Dermatology and conducts research in the laboratory of Dr Paul Khavari at Stanford, where he studies epidermal differentiation. Dr Winge completed his M.D. and Ph.D studies at Karolinska Institute in Sweden, and subsequently a research fellowship followed by dermatology residency at Stanford. His clinical interests include inflammatory skin disease as well as skin cancer.
-
Maia Winkel
Clinical Instructor, Emergency Medicine
BioMaia Winkel, MD is the current Stanford Physician Wellness Fellow, as well as a Clinical Instructor in the Department of Emergency Medicine at Stanford School of Medicine. In addition, she is both a Stanford Health Professions Education and Scholarship (SHAPES) Program Honors Scholar and a member of the Stanford Biodesign Faculty Fellowship. Prior to this, she completed Emergency Medicine residency at the Jacobi and Montefiore Medical Centers in the Bronx, NY, where she was Chief Resident. She holds a Masters in Bioethics from Columbia University.
-
Marilyn Winkleby, PhD, MPH
Professor (Research) of Medicine (Stanford Prevention Research Center), Emerita
Current Research and Scholarly InterestsCardiovascular disease epidemiology, health of socioeconomically disadvantaged populations, social determinants of health, community-based intervention research, youth advocacy and mentorship, promoting diversity in health professions
-
Virginia D. Winn, MD, PhD
Professor of Obstetrics and Gynecology (Reproductive, Perinatal & Stem Cell Biology Research)
Current Research and Scholarly InterestsThe Winn Laboratory seeks to understand the unique biological mechanisms of human placentation. While the placenta itself is one of the key characteristics for defining mammals, the human placenta is different from most available animal models: it is one of the most invasive placentas, and results in the formation of an organ comprised of cells from both the fetus and the mother. In addition to this fascinating chimerism, fetal cells are deeply involved in the remodeling of the maternal vasculature in order to redirect large volumes of maternal blood to the placenta to support the developing fetus. As such, the investigation of this human organ covers a large array of biological processes, and deals not only with understanding its endocrine function, but the physiologic process of immune tolerance, vascular remodeling, and cellular invasion.
-
Terry Winograd
Professor of Computer Science, Emeritus
BioProfessor Winograd's focus is on human-computer interaction design and the design of technologies for development. He directs the teaching programs and HCI research in the Stanford Human-Computer Interaction Group, which recently celebrated it's 20th anniversary. He is also a founding faculty member of the Hasso Plattner Institute of Design at Stanford (the "d.school") and on the faculty of the Center on Democracy, Development, and the Rule of Law (CDDRL)
Winograd was a founding member and past president of Computer Professionals for Social Responsibility. He is on a number of journal editorial boards, including Human Computer Interaction, ACM Transactions on Computer Human Interaction, and Informatica. He has advised a number of companies started by his students, including Google. In 2011 he received the ACM SIGCHI Lifetime Research Award. -
Dean Winslow
Professor of Medicine (Hospital Medicine), by courtesy, of Pediatrics (Infectious Diseases) and Senior Fellow, by courtesy, at the Freeman Spogli Institute for International Studies
BioDean Winslow, MD is Professor of Medicine and Pediatrics and is a Senior Fellow (By courtesy) at CISAC/Freeman Spogli Institute. He has served on the Stanford faculty since 1998 and from 2003-2008 as Co-Director of Stanford's Infectious Diseases Fellowship Training Program. He was in private practice in Wilmington, Delaware where he started the state’s multidisciplinary clinic for HIV patients in 1985. In 1988 he joined the DuPont Company where he worked both as a bench scientist on HIV drug resistance then designed the clinical trials supporting FDA approval of efavirenz. In 1999 he became Vice President of Regulatory Affairs at Visible Genetics Inc. and led the FDA clearance of the TRUGENE HIV-1 drug resistance test. Dr. Winslow joined the staff at Santa Clara Valley Medical Center in 2003, where he served as Chief of the Division of AIDS Medicine and later as Chair of the Department of Medicine. In 2015 he was appointed Vice Chair of the Department of Medicine at Stanford and Academic Physician-In-Chief at Stanford/ValleyCare. He was a Resident Fellow in Robinson House 2013-2017 and was visiting faculty at Oxford University in 2017. He was Lead Physician for the US Antarctic Program of the National Science Foundation 2019-2020 based at McMurdo Station, Antarctica. In March 2021 he took leave from Stanford to lead the US COVID-19 Testing and Diagnostic Working Group. He also served as CDC Senior Advisor to Operation ALLIES WELCOME and Chief Medical Officer for the Southwest Border Migrant Health Task Force before returning to Stanford in July 2022.
Dr. Winslow is a Master of the American College of Physicians, Fellow of the Royal College of Physicians, the American Academy of Pediatrics, the Infectious Diseases Society of America, and the Pediatric Infectious Diseases Society. He is the author of over 100 papers. He is,a member of the IDSA Sepsis Task Force, and previously served as Chair of the Standards and Practice Guidelines Committee.
Colonel Winslow entered the Air National Guard in 1980 and was a Distinguished Graduate of the USAF School of Aerospace Medicine. He served as Commander of the 159th Medical Group 1992-1995 and was State Air Surgeon, Delaware Air National Guard 1995-2011. He served as ANG Assistant to the Commander, 59th Medical Wing, Joint Base San Antonio 2011-2014. Colonel Winslow deployed to the Middle East six times after 9/11 as a flight surgeon supporting combat operations in Iraq and Afghanistan. From Jan-April 2003 Colonel Winslow was the flight surgeon responsible for combat rescue operations from northern Iraq to Tikrit. In 2005 he coordinated military public health in Louisiana in the aftermath of Hurricane Katrina. In 2006 Colonel Winslow served as an ER physician at the United States Air Force 447th EMEDS (combat hospital) in Baghdad and in 2008 he served as hospital commander during the Iraq surge. He is a 2007 graduate of Air War College. He served as an infectious disease consultant to the USAF Surgeon General. In 2017 Dr. Winslow was nominated by the President to serve as Assistant Secretary of Defense for Health Affairs. He has 3,000 civilian and 1,200 military flying hours including 431 combat hours and 263 combat sorties. He has extensive operational experience in fighter, tactical airlift, and combat rescue missions. He holds an FAA Airline Transport Pilot license.
Since 2006 Dr. Winslow has arranged medical care in the U.S. for 28 Iraqi children who have complicated medical conditions for which care is not available in Iraq. In 2015, Dr. Winslow and his wife, Dr. Julie Parsonnet, created The Eagle Fund of the Silicon Valley Community Foundation, which provides aid to middle eastern and central American refugees. In 2018 he co-founded Scrubs Addressing the Firearms Epidemic (SAFE), which unites health care professionals to address gun violence in the US as a public health issue and to advocate for education, research, and evidence-backed policy to reduce gun violence. -
Monte Winslow
Associate Professor of Genetics and of Pathology
Current Research and Scholarly InterestsOur laboratory uses genome-wide methods to uncover alterations that drive cancer progression and metastasis in genetically-engineered mouse models of human cancers. We combine cell-culture based mechanistic studies with our ability to alter pathways of interest during tumor progression in vivo to better understand each step of metastatic spread and to uncover the therapeutic vulnerabilities of advanced cancer cells.
-
Tamara Winston
Administrative Division Director, Surgery - Pediatric Surgery
BioM.P.A, NDNU
M.S. Management, NDNU
B.A. Political Science/Business Administration, SJSU -
Sandra Winter
Adjunct Lecturer, Medicine - Med/Stanford Prevention Research Center
BioSandra J. Winter, PhD, MHA, is currently the Executive Director of Senior Coastsiders in Half Moon Bay, CA. Senior Coastsiders is a 501(c)3 nonprofit organization that has provided opportunities, support, and resources for older adults on the San Mateo Coast since 1977. Senior Coastsiders prepares meals that are served in the dining room or home delivered; provides information assistance and caregiver support; carries out minor repairs to improve home safety; facilitates transport to and from the center; and coordinates a variety of classes and activities. Sandi is an Adjunct Lecturer at the Stanford Prevention Research Center and a member of the Community Health and Prevention Research (CHPR) Master of Science Advisory Board.
Sandi was born and raised in Zimbabwe, then moved to Cape Town in South Africa where she was a successful entrepreneur, owning and operating a number of businesses in the advertising industry. In 2003 Sandra moved with her family from Cape Town, South Africa to Lexington, Kentucky where she completed a Master of Health Administration in May, 2006 and a PhD in Public Administration (Health Policy Track) in December, 2009 at the University of Kentucky. Her graduate research work focused on the health care that is provided to prison inmates in Kentucky.
In 2009 Sandra moved from Kentucky to California where she started working at the Stanford Prevention Research Center (SPRC). At SPRC Sandra held a number of positions including Fitness assessor, biometric screener and wellness advisor with the BeWell program; Social Science Research Assistant with Abby King’s Healthy Aging Research and Technology Solutions (HARTS) lab; Project Manager for the SPRC/Qassim University College of Medicine, Saudi Arabia collaboration, Postdoctoral Research Fellow with the National Heart Lung and Blood Institute and Director of the WELL for Life initiative.
Sandra's research areas of interest include wellbeing, community-based interventions among under resourced populations; reducing health disparities (particularly in a global context); the role the environments in which we live, work and play affect our ability to lead healthy active lives; and how we can use technology to encourage and support health behavior improvements. -
Erin K. Wipff MSN, RN, ANP-BC
Affiliate, Neurosurgery
BioErin Wipff earned her Bachelors of Arts in Biology from University of California, Santa Cruz and Bachelors of Nursing from Johns Hopkins University. She received her Masters of Science in Nursing in Adult Primary Care with a minor in HIV from the University of California, San Francisco. She is board certified through the American Academy of Nurse Practitioners and a member of the California Association of Nurse Practitioners and Sigma Theta Tau. Her experience ranges from care of patients in the inpatient and outpatient settings with focuses in research, oncology, endocrinology, and neurosurgery. She currently supports the neurosurgical practice of Dr. Juan Fernandez-Miranda, Surgical Director of the Stanford Brain Tumor, Skull Base, and Pituitary Centers.
-
Paul H. Wise, MD, MPH
Richard E. Behrman, MD, Professor of Child Health and Society, Professor of Health Policy and Senior Fellow at the Freeman Spogli Institute for International Studies
Current Research and Scholarly InterestsHe is a health policy and outcomes researcher who conducts transdisciplinary research that bridges social policy, international security, and technological innovation on children's health; the impact of technical innovation on social disparities in child and maternal health; the impact of political instability and violent conflict on child health and well-being around the world
-
Emily Kay Wiseman
Casual - Non-Exempt, Radiology - Diagnostic Radiology
Current Role at Stanford3DQ Lab Technologist
-
Clay P. Wiske, MD
Clinical Assistant Professor, Surgery - Vascular Surgery
BioDr. Wiske is a vascular surgeon in the Vascular and Endovascular Care program at Stanford Health Care. He is also a clinical assistant professor of surgery in the Department of Surgery, Division of Vascular Surgery. Dr. Wiske manages and treats the full spectrum of vascular disease, performing both open and endovascular surgery.
His clinical interests include peripheral arterial disease, venous disease, dialysis access, and aortic and peripheral aneurysms. Additionally, he has helped develop and evaluate medical devices designed to maximize the ease of treatment and limit the invasiveness of specific interventions.
Dr. Wiske has published research on a variety of topics within vascular surgery. These include the best approaches to reduce the risk of stroke associated with carotid surgery and the impact of using multidisciplinary teams to identify and treat pulmonary embolisms. Dr. Wiske has also participated in studies assessing the pace of innovation in vascular surgery, as well as policy approaches to reducing the financial burden of health care on patients.
Dr. Wiske has published his work in numerous peer-reviewed journals, including the Journal of the American Medical Association, the Journal of Vascular Surgery, and Vascular and Endovascular Surgery. He has also been an invited guest speaker at national and international meetings, including those for the Society for Vascular Surgery, American Venous Forum, and the Vascular and Endovascular Surgery Society. -
Willemijn Witkam
Postdoctoral Scholar, Dermatology
BioI am a dedicated medical doctor from The Netherlands with a passion for research specializing in dermatology. My expertise spans epidemiology, exposome, microbiome, and genetics. During my postdoc at Stanford, I will study the associations of harmful environmental exposures (air pollutants, microplastics) on (inflammatory) dermatological diseases in the lab of Dr. Eleni Linos.
-
John Witte
Professor of Epidemiology and Population Health, of Biomedical Data Science and of Genetics
Current Research and Scholarly InterestsThe Witte Lab is a computational and statistical genetics group focused on deciphering the genetic and molecular mechanisms underlying cancer and other complex traits. We undertake integrative analyses across large multi-ancestry cohorts and biobanks, developing and applying methods at the interface of epidemiology, statistical genetics, and machine learning.
-
Ronald Witteles
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly Interests1) Amyloidosis -- Optimizing diagnosis/therapy and discovering new treatments
2) CardioOncology -- Understanding, treating, and preventing cancer therapy-induced cardiotoxicity
3) Sarcoidosis -- Exploring novel diagnostic modalities and determining optimal treatment, with a focus on cardiac sarcoidosis -
Temesgen 'Tem' Woldeyesus
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Tem (Temesgen) is a Clinical Assistant Professor in the Department of Medicine, Division of Primary Care and Population Health. He obtained his medical degree at UCSF and continued his residency training at UCSF in Family and Community Medicine. He was selected as Chief Resident, where he further developed as a clinical educator and administrator, prior to joining the faculty group at Stanford. His academic interests include alternative models of care, clinical informatics, and digital health equity.
Dr. Tem Woldeyesus practices full-spectrum family medicine, which includes care for the entire age spectrum. He is driven to provide evidence-based, high quality, culturally competent care.
He is a native of the Bay Area. Outside of work, he enjoys spending time with his fiancée, playing (and watching) basketball, and exploring national parks. -
Albert J. Wong, M.D.
Professor of Neurosurgery
Current Research and Scholarly InterestsOur goal is to define targets for cancer therapeutics by identifying alterations in signal transduction proteins. We first identified a naturally occurring mutant EGF receptor (EGFRvIII) and then delineated its unique signal transduction pathway. This work led to the identification of Gab1 followed by the discovery that JNK is constitutively active in tumors. We intiated using altered proteins as the target for vaccination, where an EGFRvIII based vaccine appears to be highly effective.
-
Becky Wong
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Becky Wong is board certified in adult and pediatric anesthesiology and practices anesthesiology at Stanford University Hospitals and Clinics and The Lucile Packard Children’s Hospital in Stanford, California. She received her medical school degree at The University of California at San Diego and her anesthesia residency and pediatric anesthesia fellowship training at Stanford. She provides anesthesia care for a wide range of ages with a focus on neuroanesthesia. She co-chairs the Neuroanesthesia Special Interest Group in the Society for Pediatric Anesthesia. As an Associate Director for Quality Improvement in the Stanford Anesthesia Department, she has a deep interest in improving patient care.
-
David J. Wong, MD, PhD
Clinical Associate Professor, Dermatology
Current Research and Scholarly InterestsMy research interest is focused on investigating the molecular networks that underlie cancer stem cells and designing therapies that selectively target these cells, thereby eliminating a cancer's potential for regrowth.
-
Evelyn Wong
MD Student, expected graduation Spring 2028
Ph.D. Student in Bioengineering, admitted Spring 2026
Ph.D. Student in Biophysics, admitted Autumn 2025
MSTP StudentCurrent Research and Scholarly InterestsSoft bioelectronics for multi-modal sensing and neural stimulation
-
Jadene Wong
Clinical Associate Professor, Pediatrics - Neonatology
Current Research and Scholarly Interests- Care of the Infant with Neonatal Opioid Withdrawal Syndrome (NOWS)
https://www.cpqcc.org/resources/neonatal-opioid-withdrawal-syndrome-nows-toolkit
https://nastoolkit.org/
https://podcasts.apple.com/us/podcast/episode-17-neonatal-abstinence-syndrome-dr-jadene-wong/id1581530231?i=1000558004429
- Primary Care for Preterm Infants and Children
https://www.cpqcc.org/preterm-primary-care-toolkit -
Ronald J. Wong
Sr Res Scientist-Basic Ls, Pediatrics - Neonatology
Current Role at StanfordSenior Research Scientist
-
Wing Hung Wong
Stephen R. Pierce Family Goldman Sachs Professor of Science and Human Health and Professor of Biomedical Data Science
Current Research and Scholarly InterestsCurrent interest centers on the application of statistics, computation and engineering approaches to biology and medicine. We are particularly interested in questions concerning gene regulation, genome interpretation and their applications to precision medicine.
-
Jennifer Woo, MD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
Clinical Assistant Professor, Pediatrics - CardiologyBioDr. Woo is a board-certified, fellowship-trained cardiologist with the Adult Congenital Heart Program at Stanford Health Care. She is also a clinical assistant professor in the Divisions of Cardiovascular Medicine and Pediatric Cardiology at Stanford University School of Medicine.
She diagnoses and treats a range of cardiovascular diseases, with a focus on adult congenital heart disease. Dr. Woo has Level III training with the National Board of Echocardiography, a certification that recognizes her experience in complex cardiac imaging. She also has specialized expertise in cardiac MRI. Each of her patients receives a personalized, comprehensive care plan delivered with compassion.
Dr. Woo is heavily involved in adult congenital heart disease research. She has a particular interest in imaging and heart failure in adults with congenital heart disease. She has received grant funding for her work, including from the Adult Congenital Heart Association. The National Institutes of Health awarded granted her the Ruth L. Kirschstein National Research Service Award.
She has published research in several peer-reviewed journals, such as the Journal of the American College of Cardiology and Pediatric Cardiology. Dr. Woo has presented her findings at regional and national meetings, including the Adult Congenital Heart Disease Bay Area Conference and the International Symposium on Adult Congenital Heart Disease.
Dr. Woo is a member of the Adult Congenital Heart Association, American College of Cardiology, American Heart Association, and American Society of Echocardiography. -
Joseph Woo, MD, FACS, FACC, FAHA
Norman E. Shumway Professor, Professor of Cardiothoracic Surgery and, by courtesy, of Bioengineering
BioDr. Woo is a board-certified, fellowship-trained cardiothoracic surgeon, cardiovascular surgeon, and transplant surgeon with Stanford Health Care. He is professor and chair of the Stanford Medicine Department of Cardiothoracic Surgery and associate director of the Stanford Cardiovascular Institute. He is also the Norman E. Shumway Professor of Cardiothoracic Surgery and professor, by courtesy, in the Department of Bioengineering.
Dr. Woo is a nationally recognized surgeon, innovator, researcher, and educator in cardiothoracic surgery. He focuses on complex mitral and aortic valve repair, thoracic aortic surgery, heart and lung transplantation, and minimally invasive heart surgery. He was awarded the American Heart Association’s 2021 Clinical Research Prize for developing innovative and minimally invasive surgeries to repair and reconstruct heart valves.
In 2022, Dr. Woo and his team at Stanford Health Care performed the first beating-heart transplant from a donation after circulatory death (DCD) donor and organ perfusion system. Keeping a donor heart pumping while it’s transported to the recipient and then implanting the heart while it’s beating minimizes organ damage. This groundbreaking new procedure is expected to increase the number of hearts available for transplant while improving health outcomes.
As a physician-scientist, Dr. Woo has served as principal investigator on multiple studies funded by National Institutes of Health (NIH) grants. One explored an innovative therapy to stimulate vascular (blood-carrying) stem cells in the bone marrow and direct them to the heart to grow new blood vessels and improve blood flow to damaged heart muscle.
Dr. Woo has also been the primary investigator for clinical trials involving the administration of stem cells during coronary artery bypass grafting (CABG) and left ventricular assist device (LVAD) implantation. In addition, Dr. Woo has served as primary investigator for multiple clinical device trials. He has filed for and holds patents for several heart-related medical devices and surgical techniques.
Dr. Woo has co-authored more than 510 articles in peer-reviewed journals and has served as a reviewer for many of them, including the Annals of Thoracic Surgery, Journal of Thoracic and Cardiovascular Surgery, and Circulation. He has also presented his research and performed live surgery demonstrations both nationally and internationally.
Dr. Woo serves as president of the American Association for Thoracic Surgery (AATS) and past president of the AATS Cardiac Surgery Biology Club. He is a fellow of the American College of Surgeons, American College of Cardiology, and American Heart Association. He is a member of many other professional societies, including the World Society of Cardiovascular and Thoracic Surgeons and International Society for Heart Research. He also serves on the leadership committee of the American Heart Association’s Council on Cardiovascular Surgery and Anesthesia. -
Jennifer Woo Baidal
Associate Professor of Pediatrics (Gastroenterology) and, by courtesy, of Epidemiology and Population Health
BioJennifer Woo Baidal is Associate Professor of Pediatrics, with tenure, and Associate Chair for Clinical Research in the Department of Pediatrics at Stanford University School of Medicine. She is also Chair for the North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) Research Committee and a member of the American Academy of Pediatrics (AAP) Committee on Nutrition.
As the Principal Investigator for the Childhood Research in Obesity Prevention (CROP) lab, she has experience successfully obtaining funding through National Institutes of Health, PCORI, Robert Wood Johnson Foundation, and Doris Duke Foundation to lead action-oriented child health research. Dr. Woo Baidal’s health services research program aims to improve health for all children, with a focus on reducing childhood obesity. Her research program translates clinical, community, and epidemiologic findings into population-level interventions during pregnancy, infancy, and early childhood to reduce food insecurity, improve nutrition, and prevent childhood obesity and related chronic diseases. She has shown the vital role of early life factors on chronic disease prevention, including the promise of 'food as prevention' for infants in households with food insecurity. Her work has been featured by the New York Times, NPR, and CNN, and cited in AAP guidelines and by the National Academies of Science and Medicine. In 2023, she was honored with the AAP's Mitchell B Cohen Early to Mid-Career Leadership Award. -
Douglas Wood
Affiliate, Technology & Digital Solutions
Current Role at StanfordWorking within the School of Medicine, I am developing solutions for the Stanford Bone Marrow Transplant, Lymphoma, and Cancer Institute Research Databases
My Stanford Projects:
- Stanford Cancer Center Research Database (SCIRDB)
Developed a web-based platform to integrate data from the Stanford Cancer Institute (EPIC/Clarity), Stanford Tumor Registry, STRIDE (Tissue Bank & Pre-EPIC Data), and several other systems into a "one-stop shop" for data analysis and annotation by cancer researchers. This cohort-driven system allows users to focus on their patients of interest and provides free-text search of all their notes, reports and narratives as well as a timeline-based view of all events for a patient. Easy exports allow for data analysis in biostatistical tools and the system can perform complex analysis using the open-source R statistical software as a service.
- Lymphoma Program Project (LPP)
Rearchitected an existing legacy database system that tracks Stanford's Non-Hodgkins and Hodgkins Lymphoma cases back to the late 1960's. Enables clinicians to track diagnosis, courses of treatment, long-term follow-up, and clinical responses to the diseases.
- Bone Marrow Transplant Program
Developed replacement web-enabled database based on legacy system in place since 1980s that enhanced data capture abilities by leveraging data feeds from BMT Clinic and Stanford Hospital. Also enabled electronic form submission to national transplant databank via XML-based web-services.
- Transplant Arteriosclerosis, Viral and Host Mechanisms
Developed web-based application and reporting systems Gathered requirements, translated requirements into technical specifications, built reporting tools, designed table schemas, migrated database tables from Access to Oracle, normalizing and validating data in the process. Wrote all SQL scripts for automating data migration.
- Stanford Asian Pacific Program in Hypertension and Insulin Resistance (SAPPHIRe)
Provided on-going maintenance for the project by uploading data, generating reports for statistical analysis and modifying table schema to incorporate new measurements such as creatinine.
- GenePad Project
Developed a web-based tool for quality assurance of scanned form data that allows users to view scanned input and validate it before storing it into final database tables. The tool dynamically configures itself by examining the structure of the database. -
Helen J. Wood
Affiliate, Psych/Public Mental Health & Population Sciences
BioDr. Helen Wood (she/her) is a clinical psychologist licensed in Vermont and Pennsylvania. She works for INSPIRE training and is also a Clinical Associate Professor at the University of Vermont, Department of Psychological Science. Dr. Wood was previously the psychologist for outpatient psychosis services, including a first-episode psychosis service, at an academic medical center in southwest Pennsylvania, where she led CBTp implementation. She has worked as program director for an adult psychosis inpatient unit, as well as in outpatient services in the US and in the UK’s National Health Service. She co-chairs the North American CBTp Network’s early psychosis working group. Dr. Wood values collaboration with people bringing lived experience knowledge to clinical, training, and research contexts. Dr. Wood’s clinical and research interests focus on understanding the experience of psychosis and improving services and/or other forms of support. Dr. Wood has a BA Hons in History, Theology and Religious Studies from the University of Cambridge, an MSc in Experimental Psychology from the University of Sussex, and a Doctorate in Clinical Psychology from Canterbury Christ Church University, all in the UK.
-
Tracey Woodruff
Professor of Epidemiology and Population Health and Senior Fellow at the Woods Institute for the Environment
BioMy research is devoted to identify and addressing environmental pollution exposures - petrochemicals, pesticides, plastics and other toxic contaminants - and the impacts on health. I focus on filling critical gaps in knowledge that will result in structural changes that improve health and reduce inequities. I collaborate across disciplines to create systemic solutions that integrate environmental health, public policy, and healthcare for significant public health advancements. My research expertise encompasses all aspects of understanding and characterizing environmental chemical exposures and their health impacts, especially on vulnerable and susceptible populations due to life stage, such as pregnant women and children, and demographics, such as poverty and race/ethnicity. I led multidisciplinary investigations to: identify and measure human exposures to environmental contaminants via modeling and biomonitoring including advanced methods for nontargeted analysis; identify biological mechanisms using in vitro and in vivo systems; assess the impact of multiple chemical exposures on pregnancy and child outcomes via epidemiology studies; and develop and apply methods for translating research findings into improved clinical care and public policy.
I have extensive expertise and experience in translating science into clinical and policy decision-making. I led the development of the Navigation Guide Systematic Review Methodology, the first systematic review method for environmental health science, developed in collaboration with multiple collaborators from international, national, and state governments, community groups, and the clinical community, integrates best practices from clinical medicine and environmental health evaluation. I continue to collaborate on systematic reviews including pesticides and Parkinson’s, and methodological improvements. I am widely recognized for my expertise in the use of science in decision making for environmental chemicals. I’ve been invited to testify before Congress and the State of California multiple times and I lead our Science Action Network that engages in bring best available science to regulatory decision-making. I have also collaborated with other faculty on empirical research to identify how industries adversely influence the scientific process.
Before Stanford, I was a Professor at UCSF and Director of the Program on Reproductive Health and the Environment. I now with UCSF co-lead the UCSF/Stanford Environmental Research and Translation for Health Center funded by a NIEHS P30 mechanism. Prior to UCSF I served for over 10 years in the Office of Policy at the US Environmental Protection Agency. -
Emily Woods
Postdoctoral Scholar, Pathology
Current Research and Scholarly Interestsdevelopment of activity-based probes for specific diagnosis and treatment of Staphylococcus aureus infections and for detection of bacterial ear infections (otitis media)
